Mayne Pharma

Activities: Manufacturing Pharmaceutical

Trending Articles

  1. Isospec launches analysis technology to identify unknown molecules The novel technology can facilitate the detection of trace amounts of unidentified molecules in nutraceutical formulations
  2. Kyowa Hakko’s IMMUSE powers Sensilab’s new IMMUNOFAR Biotic for enhanced immune support The incorporation of IMMUSE facilitates the strengthening of pDC functionality, promoting a healthy immune system
  3. Degradation of vitamins, probiotics and other active ingredients caused by exposure to heat, water and sunlight Vitamins and probiotics (and other active ingredients) can be substantially affected by exposure to heat, water and/or sunlight
  4. Glanbia acquires Flavor Producers for $300m The acquisition adds significantly to Glanbia's Better Nutrition platform, introducing novel flavour offerings
  5. The role of traceability in the nutraceutical supply chain The exponential growth of the nutraceutical sector, combined with the unprecedented growth in online marketplaces, makes nutraceuticals highly vulnerable to vast counterfeiting...

Upcoming event

Vitafoods Europe

14–16 May 2024 | Exhibition | Palexpo, Geneva See all

Related Content

Manufacturing

Drug dose delivery development, manufacturing and commercialisation trends: part II

In the wake of patient-centricity in the pharmaceutical industry, drug delivery technologies have emerged as a central driver of therapeutic and patient success. Dr Kevin Robinson went online with Manuel Leal, Business Development Director, Idifarma, Steve Rode, Manager Business Development, Capsules and Health Ingredients, Lonza, and John Ross, President, Mayne Pharma US/Metrics Contract Services, to find out more
Manufacturing

Drug dose delivery development, manufacturing and commercialisation trends: part I

In the wake of patient-centricity in the pharmaceutical industry, drug delivery technologies have emerged as a central driver of therapeutic and patient success. Dr Kevin Robinson went online with Manuel Leal, Business Development Director, Idifarma, Steve Rode, Manager Business Development, Capsules and Health Ingredients, Lonza, and John Ross, President, Mayne Pharma US/Metrics Contract Services, to find out more
Subscribe now